Companies › BEAM

BEAM THERAPEUTICS INC (BEAM)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001745999 · EDGAR filings · Updated 2026-07-27

BEAM THERAPEUTICS INC (BEAM) has reported institutional ownership of 105.2%, with 249 institutional managers holding positions valued at $2.58B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-27 — Notice of proposed sale filed (Form 144)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-07-01 — Insider transaction reported (Form 4)
• 2026-06-30 — Notice of proposed sale filed (Form 144)
• 2026-06-29 — Notice of proposed sale filed (Form 144)
• 2026-06-29 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BEAM THERAPEUTICS INC has 249 institutional holders and institutional ownership of 105.2%.

Insider activity

Insiders reported 41 transactions (0 buys, 27 sells) across 7 reporting insiders, with a net reported value of −$7.45M.

Related companies

HAEMONETICS CORP MASS (HAE) · 10X GENOMICS INC (TXG) · CATALYST PHARMACEUTICALS INC (CPRX) · ARCUS BIOSCIENCES INC COM (RCUS) · ORUKA THERAPEUTICS INC (ORKA) · IMMUNOME INC (IMNM)